Egyptian Rheumatology and Rehabilitation

Table 3 Spearman’s correlation of hip and major fractures FRAX with other variables in the studied subjects in the RA group

From: Evaluation of fracture risk in Egyptian rheumatoid arthritis patients by the Fracture Risk Assessment Tool

	FRAX
	r	P value
Major fractures
Age	0.824	< 0.0001
BMI	− 0.601	< 0.0001
Menopause years	0.529	< 0.0001
Serum calcium	− 0.032	0.75
Serum phosphorous	− 0.047	0.637
HAQ-DI	0.623	< 0.0001
Cumulative steroid dose	0.368	0.001
Current steroid dose	0.115	0.079
DAS28-ESR	0.321	0.041
DAS28-CRP	0.355	0.031
BMD of total femur (gm/cm²)	− 0.733	< 0.0001
BMD of femoral neck (gm/cm²)	− 0.836	< 0.0001
BMD of lumbar spine (gm/cm²)	− 0.733	< 0.0001
Hip FRAX	0.913	< 0.0001
Hip
Age	0.731	< 0.0001
BMI	− 0.652	< 0.0001
Menopausal years	0.606	< 0.0001
Serum calcium	− 0.06	0.54
Serum phosphorous	− 0.111	0.27
HAQ-DI	0.595	< 0.0001
Cumulative steroid dose	0.410	0.001
Current steroid dose	0.128	0.086
DAS28-ESR	0.362	0.037
DAS28-CRP	0.375	0.012
BMD of total femur (gm/cm²)	− 0.794	< 0.0001
BMD of femoral neck (gm/cm²)	− 0.920	< 0.0001
BMD of lumbar spine (gm/cm²)	− 0.795	< 0.0001
Major fractures FRAX	0.913	< 0.0001

*Statistically significant at P ≤ 0.05, FRAX fracture risk assessment for 10 years fracture probability, BMI body mass index, HAQ-DI Health Assessment Questionnaire Disability Index, ESR erythrocyte sedimentation rate, CRP C-reactive protein, DAS28-ESR 28 joints disease activity score calculated with ESR, DAS28-CRP 28 joints disease activity score calculated with CRP, BMD bone mineral density

Back to article page